Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).
Quaquarini E, Saltalamacchia G, Presti D, Caldana G, Tibollo V, Malovini A, Palumbo R, Teragni CM, Balletti E, Mollica L, Biscaldi E, Frascaroli M, Bernardo A, Sottotetti F. Quaquarini E, et al. Among authors: mollica l. Cancers (Basel). 2020 Oct 12;12(10):2941. doi: 10.3390/cancers12102941. Cancers (Basel). 2020. PMID: 33053782 Free PMC article.
Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA).
Morasso C, Ricciardi A, Sproviero D, Truffi M, Albasini S, Piccotti F, Sottotetti F, Mollica L, Cereda C, Sorrentino L, Corsi F. Morasso C, et al. Among authors: mollica l. Breast Cancer Res Treat. 2022 Feb;192(1):65-74. doi: 10.1007/s10549-021-06474-3. Epub 2021 Dec 21. Breast Cancer Res Treat. 2022. PMID: 34935096 Free PMC article.
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, Balletti E, Leli C, Premoli A, Mollica L, Puglisi S, Sardi S, Malovini A, Pedrazzoli P, Bernardo A. Sottotetti F, et al. Among authors: mollica l. Drugs Context. 2022 Sep 5;11:2022-1-3. doi: 10.7573/dic.2022-1-3. eCollection 2022. Drugs Context. 2022. PMID: 36118250 Free PMC article.
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2- breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
Tagliaferri B, Mollica L, Palumbo R, Leli C, Malovini A, Terzaghi M, Quaquarini E, Teragni C, Maccarone S, Premoli A, Sottotetti F. Tagliaferri B, et al. Among authors: mollica l. Drugs Context. 2023 Jun 20;12:2023-1-7. doi: 10.7573/dic.2023-1-7. eCollection 2023. Drugs Context. 2023. PMID: 37378079 Free PMC article.
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study.
Palumbo R, Quaquarini E, Saltalamacchia G, Malovini A, Lapidari P, Tagliaferri B, Mollica L, Teragni CM, Barletta C, Locati LD, Sottotetti F. Palumbo R, et al. Among authors: mollica l. Drugs Context. 2024 Feb 5;13:2023-7-5. doi: 10.7573/dic.2023-7-5. eCollection 2024. Drugs Context. 2024. PMID: 38332945 Free PMC article.
Preventive strategies for acute kidney injury in cancer patients.
Cosmai L, Porta C, Foramitti M, Perrone V, Mollica L, Gallieni M, Capasso G. Cosmai L, et al. Among authors: mollica l. Clin Kidney J. 2020 Nov 28;14(1):70-83. doi: 10.1093/ckj/sfaa127. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564407 Free PMC article. Review.
YY1 mutations disrupt corticogenesis through a cell-type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs.
Pereira MF, Finazzi V, Rizzuti L, Aprile D, Aiello V, Mollica L, Riva M, Soriani C, Dossena F, Shyti R, Castaldi D, Tenderini E, Carminho-Rodrigues MT, Bally JF, de Vries BBA, Gabriele M, Vitriolo A, Testa G. Pereira MF, et al. Among authors: mollica l. bioRxiv [Preprint]. 2024 Feb 17:2024.02.16.580337. doi: 10.1101/2024.02.16.580337. bioRxiv. 2024. PMID: 38405909 Free PMC article. Preprint.
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.
Seidizadeh O, Mollica L, Zambarbieri S, Baronciani L, Cairo A, Colpani P, Cozzi G, Pagliari MT, Ciavarella A, Siboni SM, Peyvandi F. Seidizadeh O, et al. Among authors: mollica l. Blood Adv. 2024 Apr 9;8(7):1725-1736. doi: 10.1182/bloodadvances.2024012626. Blood Adv. 2024. PMID: 38315875 Free PMC article.
90 results